|
Clinical Data, Inc. - Comparative Business Analysis Snapshot
Business Description
Clinical Data, Inc.. The Group's principal activity is to focus on the development and commercialization of targeted therapeutics and predictive tests, and to provide world-leading value-based genomic solutions to both the healthcare and life sciences industries. The Group operates business in two segments: PGxHealth and Cogenics. It operates in the United States, North America, Europe, Asia and Other foreign countries. The Group also acquired Epidauros Biotechnologie A.G. last August 23, 2007.
Competitor Analysis
This analysis compares Clinical Data, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
